ESC Professional Premium Access

Rhythm and valvular heart disease

Event: ESC Congress 2022
Topic: Clinical
Session type: Moderated ePosters
Date: 29 August 2022
Time: 10:15 - 11:00

Congress Session

7 presentations in this session

Predictors of ventricular arrhythmias in arrhythmic mitral valve syndrome - a study using implantable loop recorders

Speaker: Doctor E. Aabel (Oslo, NO)

Impact of atrial fibrillation in clinical outcomes of low gradient aortic stenosis

Speaker: Doctor N. Kolluri (Rochester, US)

Ventricular arrhythmias and sudden cardiac death caused by mitral valve prolapse: should we operate and when?

Speaker: Doctor J. Cameron (Melbourne, AU)

Clinical and prognosis assessment of Atrial Fibrillation patients with significant valvular disease. Validation of the EHRA valve classification (Evaluated Heartvalves. Rheumatic or Artificial)

Speaker: Doctor A. Escolar Conesa (El Palmar, ES)

The impact of right atrium and left atrium reverse remodeling for functional regurgitation of atrioventricular valve among patients who were underwent ablation for atrial fibrillation

Speaker: Doctor N. Nemoto (Ota-Shi, JP)

Exercise-induced ventricular arrythmia in asymptomatic patients with Mitral Valve Prolapse

Speaker: Doctor T. Wallet (Paris, FR)

The impact of atrial fibrillation on prognosis in aortic stenosis

Speaker: Doctor D. Laenens (Leiden, NL)

7 speakers from this session

Doctor Eivind Aabel

Oslo University Hospital Rikshospitalet, Oslo (Norway)
2 presentations
0 follower

Doctor Nikhil Kolluri

Mayo Clinic, Rochester (United States of America)
0 follower

Doctor James Cameron

Austin Hospital, Melbourne (Australia)
0 follower

Doctor Antonio Escolar Conesa

Virgen of the Arrixaca University Clinical Hospital, El Palmar (Spain)
0 follower

Doctor Naohiko Nemoto

Ota Memorial Hospital, Ota-Shi (Japan)
0 follower

Doctor Thomas Wallet

Pitie Salpetriere APHP University Hospital, Paris (France)
0 follower

Doctor Dorien Laenens

Leiden University Medical Center, Leiden (Netherlands (The))
1 presentation
0 follower

This platform is supported by

logo Novo Nordisk